Viewing StudyNCT05966467



Ignite Creation Date: 2024-05-06 @ 7:18 PM
Last Modification Date: 2024-10-26 @ 3:04 PM
Study NCT ID: NCT05966467
Status: RECRUITING
Last Update Posted: 2024-02-01
First Post: 2023-07-07

Brief Title: Registry of Patients With AQP4 NMOSD Treated With Alexion C5 Inhibitor Therapies
Sponsor: Alexion Pharmaceuticals Inc
Organization: Alexion Pharmaceuticals Inc

Conditions & Keywords Data

Conditions:
Name
AQP4 NMOSD
Neuromyelitis Optica Spectrum Disorder
NMOSD
Keywords:
Name View
Soliris View
Neuromyelitis Optica Spectrum Disorder View
NMOSD View
C5 Inhibitor Therapies View
AQP4 NMOSD View
Patient Registry View
Alexion C5IT View